Key, A., A. Pederson, J. Sant, and C. Ray. “Teprotumumab-Associated Hearing-Related Adverse Events”. The Southwest Respiratory and Critical Care Chronicles, Vol. 12, no. 50, Jan. 2024, pp. 24-29, doi:10.12746/swrccc.v12i50.1261.